No abstract available
MeSH terms
-
Aged
-
Alemtuzumab
-
Antibodies, Monoclonal / administration & dosage*
-
Antibodies, Monoclonal / pharmacology
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Neoplasm / administration & dosage*
-
Antibodies, Neoplasm / pharmacology
-
Antineoplastic Agents / administration & dosage*
-
Antineoplastic Agents / pharmacology
-
Dose-Response Relationship, Drug
-
Female
-
Humans
-
Injections, Intravenous
-
Injections, Subcutaneous
-
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
-
Male
-
Middle Aged
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Neoplasm
-
Antineoplastic Agents
-
Alemtuzumab